| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | NTRA Natera, Inc. | Chapman Rowan E52 | Director | Sell | 1,998 | $55.97 | $111,830.86 | -17.6% | +34.5% | +196.2% | |
| Nov 28, 2023 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 642 | $305.10 | $195,874.20 | -8.5% | +11.1% | +11.2% | |
| Nov 28, 2023 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | - | Sell | 46,833 | $274.96 | $12,877,318.78 | -0.4% | +49.0% | +25.3% | |
| Nov 28, 2023 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 46,833 | $274.96 | $12,877,318.78 | -0.4% | +49.0% | +25.3% | |
| Nov 27, 2023 | RDNT Radnet, Inc. | Gordon Christine Nayoma | - | Sell | 3,000 | $32.40 | $97,200.00 | -22.4% | +18.4% | +149.2% | |
| Nov 24, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 600 | $20.03 | $12,018.00 | -0.2% | +22.5% | +49.9% | |
| Nov 24, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 800 | $20.02 | $16,016.00 | -0.4% | +22.5% | +49.9% | |
| Nov 22, 2023 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | - | Sell | 25,000 | $277.81 | $6,945,250.00 | -0.4% | +38.7% | +23.5% | |
| Nov 22, 2023 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 25,000 | $277.81 | $6,945,250.00 | -0.4% | +38.7% | +23.5% | |
| Nov 21, 2023 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | - | Sell | 25,000 | $277.37 | $6,934,250.00 | -0.4% | +39.0% | +18.0% | |
| Nov 21, 2023 | NTRA Natera, Inc. | Marcus Gail Boxer | Director | Sell | 1,000 | $54.31 | $54,313.60 | -4.6% | +30.5% | +211.2% | |
| Nov 21, 2023 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 25,000 | $277.37 | $6,934,250.00 | -0.4% | +39.0% | +18.0% | |
| Nov 21, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 6,055 | $20.04 | $121,330.20 | -1.3% | +29.5% | +46.8% | |
| Nov 21, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 5,610 | $20.03 | $112,376.88 | -0.7% | +29.5% | +46.8% | |
| Nov 20, 2023 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,566 | $55.00 | $141,130.00 | -1.2% | +28.5% | +195.9% | |
| Nov 20, 2023 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | - | Sell | 100,000 | $274.68 | $27,468,000.00 | -0.9% | +39.2% | +14.1% | |
| Nov 20, 2023 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 100,000 | $274.68 | $27,468,000.00 | -0.9% | +39.2% | +14.1% | |
| Nov 20, 2023 | CRL Charles River Laboratories International, Inc. | Girshick Birgit65 | Corporate Executive VP &COO | Buy | 1,322 | $187.82 | $248,298.04 | +3.1% | +25.4% | -2.3% | |
| Nov 17, 2023 | NEO Neogenomics Inc | Olivo Alicia C69 | General Counsel | Sell | 2,669 | $18.39 | $49,082.91 | -6.7% | -23.2% | -22.5% | |
| Nov 17, 2023 | WGS Genedx Holdings Corp. | Ryan Jason65 | Executive Chairman | Buy | 114,742 | $1.41 | $161,367.97 | +202.2% | +178.1% | +4176.9% | |
| Nov 16, 2023 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 1,617 | $27.25 | $44,065.03 | -0.4% | -5.8% | -37.4% | |
| Nov 16, 2023 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 1,344 | $1.04 | $1,397.76 | -0.7% | +16.0% | +277.7% | |
| Nov 16, 2023 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 940 | $1.04 | $977.60 | -0.8% | +16.0% | +277.7% | |
| Nov 16, 2023 | PSNL Personalis, Inc. | Moore Stephen Michael52 | General Counsel | Sell | 1,722 | $1.04 | $1,790.88 | -2.1% | +16.0% | +277.7% | |
| Nov 16, 2023 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 1,307 | $27.25 | $35,617.19 | -0.6% | -5.8% | -37.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.